Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “monoclonal”

203 pharma patents match "monoclonal" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 203
Index total 30,257
Page 4 / 9

Quick answer

This filtered view shows 203 pharmaceutical patents matching "monoclonal" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

203 results for “monoclonal” · 30,257 patents in full index Clear search

  1. US 10023650

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted
  2. US 9969803

    Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted May 15, 2018 · Expires May 10, 2038

    granted
  3. US 9938344

    Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted
  4. US 9932406

    Human monoclonal antibodies specific for glypican-3 and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 3, 2018 · Expires Mar 29, 2038

    granted
  5. US 9926380

    Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease

    The Board of Regents of the University of Texas System · Granted Mar 27, 2018 · Expires Mar 22, 2038

    granted
  6. US 9902780

    Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

    The Regents of the University of California · Granted Feb 27, 2018 · Expires Feb 22, 2038

    granted
  7. US 9845350

    Monoclonal antibodies that react with the capsule of bacillus anthracis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 19, 2017 · Expires Dec 14, 2037

    granted
  8. US 9815887

    Monoclonal antibodies that neutralize a norovirus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 14, 2017 · Expires Nov 9, 2037

    granted
  9. US 9803022

    Mesothelin domain-specific monoclonal antibodies and use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted
  10. US 9790274

    Monoclonal antibodies targeting EpCAM for detection of prostate cancer lymph node metastases

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted
  11. US 9783596

    Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephalitis virus (JEV) and their use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  12. US 9738726

    HER2-specific monoclonal antibodies and conjugates thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  13. US 9738720

    Monoclonal antibodies against HER2 epitope and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted
  14. US 9725520

    HER3 specific monoclonal antibodies for diagnostic and therapeutic use

    The Board of Regents of the University of Texas System · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  15. US 9708392

    Monoclonal antibodies against orthopoxviruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 18, 2017 · Expires Jul 13, 2037

    granted
  16. US 9676846

    Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  17. US 9663585

    Anti-DCLK1 monoclonal antibodies and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted May 30, 2017 · Expires May 25, 2037

    granted
  18. US 9605077

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted
  19. US 9598492

    Human monoclonal antibodies specific for CD22

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 21, 2017 · Expires Mar 16, 2037

    granted
  20. US 9593162

    Internalizing human monoclonal antibodies targeting prostate cancer cells in situ

    The Regents of the University of California · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  21. US 9592290

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  22. US 9592238

    Anti-ceramide monoclonal antibody 2A2

    The Board of Regents of the University of Texas System · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  23. US 9580492

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 28, 2017 · Expires Feb 23, 2037

    granted
  24. US 9567402

    Internalizing human monoclonal antibodies targeting prostate and other cancer cells

    The Regents of the University of California · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted